Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

Nature Structural and Molecular Biology

Volumn 11, Issue 5, 2004, Pages 435-442

  Yu, Qin ^a   König, Renate ^a   Pillai, Satish ^b   Chiles, Kristopher ^a   Kearney, Mary ^c   Palmer, Sarah ^c   Richman, Douglas ^d,e   Coffin, John M ^c   Landau, Nathaniel R ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTOSINE; DOUBLE STRANDED DNA; SINGLE STRANDED DNA; THYMIDINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA RNA HYBRIDIZATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS GENOME; VIRUS MUTATION;

GENOME, VIRAL; HIV; NUCLEOSIDE DEAMINASES; PROTEINS; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 2342633240     PISSN: 15459993     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsmb758     Document Type: Article

References (36)

1. Strebel, K. et al. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328, 728-730 (1987).
2. von Schwedler, U., Song, J., Aiken, C. & Trono, D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67, 4945-4955 (1993).
3. + T lymphocytes. J. Virol. 66, 6489-6495 (1992).
4. Madani, N. & Kabat, D. An endogenous Inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral VIf protein. J. Virol. 72, 10251-10255 (1998).
5. Simon, J.H. et al. The regulation of primate immunodeficiency virus infectivity by VIf is cell species restricted: a role for VIf in determining virus host range and cross-species transmission. EMBO J. 17, 1259-1267 (1998).
6. Sheehy, A.M., Gaddis, N.C., Choi, J.D. & Malim, M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650 (2002).
7. Goncalves, J., Korin, Y., Zack, J. & Gabuzda, D. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70, 8701-8709 (1996).
8. Simon, J.H. & Malim, M.H. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70, 5297-5305 (1996).
9. Mariani, R. et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31 (2003).
10. Lecossier, D., Bouchonnet, F., Clavel, F. & Hance, A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112 (2003).
11. Zhang, H. et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98 (2003).
12. Mangeat, B. et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103 (2003).
13. Harris, R.S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809 (2003).
14. Stopak, K., de Noronha, C., Yonemoto, W. & Greene, W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12, 591-601 (2003).
15. Marin, M., Rose, K.M., Kozak, S.L. & Kabat, D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9, 1398-1403 (2003).
16. Yu, X. et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060 (2003).
17. Sheehy, A.M., Gaddis, N.C. & Malim, M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9, 1404-1407 (2003).
18. Jarmuz, A. et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296 (2002).
19. Harris, R.S., Petersen-Mahrt, S.K. & Neuberger, M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247-1253 (2002).
20. Yang, Y., Sowden, M.P. & Smith, H.C. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1. J. Biol. Chem. 275, 22663-22669 (2000).
21. Lau, P.P. et al. A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. J. Biol. Chem. 276, 46445-46452 (2001).
22. Anant, S., MacGinnitie, A.J. & Davidson, N.O. apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J. Biol. Chem. 270, 14762-14767 (1995).
23. Muto, T., Muramatsu, M., Taniwaki, M., Kinoshita, K. & Honjo, T. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 68, 85-88 (2000).
24. Wedekind, J.E., Dance, G.S., Sowden, M.P. & Smith, H.C. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet. 19, 207-216 (2003).
25. Petersen-Mahrt, S.K., Harris, R.S. & Neuberger, M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-103 (2002).
26. Schrofelbauer, B., Chen, D. & Landau, N.R. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA 101, 3927-3932 (2004).
27. Schroder, A.R. et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529 (2002).
28. Dickerson, S.K., Market, E., Besmer, E. & Papavasiliou, F.N. AID mediates hypermutation by deaminating single-stranded DNA. J. Exp. Med. 197, 1291-1296 (2003).
29. Charneau, P. & Clavel, F. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J. Virol. 65, 2415-2421 (1991).
30. Vartanian, J.P., Henry, M. & Wain-Hobson, S. Sustained G→A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. J. Gen. Virol. 83, 801-805 (2002).
31. Borman, A.M., Quillent, C., Charneau, P., Kean, K.M. & Clavel, F. A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G→A hypermutation during negative-strand viral DNA synthesis. Virology 208, 601-609 (1995).
32. Berkhout, B. & van Hemert, F.J. The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res. 22, 1705-1711 (1994).
33. Berkhout, B., Grigoriev, A., Bakker, M. & Lukashov, V.V. Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. AIDS Res. Hum. Retroviruses 18, 133-141 (2002).
34. Paxton, W., Connor, R.I. & Landau, N.R. Incorporation of Vpr into human immunodeficiency virus type-1 virions: requirement for the p6 region of gag and mutational analysis. J. Virol. 67, 7229-7237 (1993).
35. Rose, P.P. & Korber, B.T. Detecting hypermutations in viral sequences with an emphasis on G→A hypermutation. Bioinformatics 16, 400-401 (2000).
36. Petersen-Mahrt, S.K. & Neuberger, M.S. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J. Biol. Chem. 278, 19583-19586 (2003).